Vanguard Group’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.9M | Buy |
|
|||||
|
2025
Q1 | $61.3M | Sell |
|
|||||
|
2024
Q4 | $72.5M | Buy |
|
|||||
|
2024
Q3 | $72.9M | Sell |
|
|||||
|
2024
Q2 | $58.9M | Buy |
|
|||||
|
2024
Q1 | $65.8M | Buy |
|
|||||
|
2023
Q4 | $22.8M | Buy |
|
|||||
|
2023
Q3 | $12.8M | Buy |
|
|||||
|
2023
Q2 | $20.9M | Buy |
|
|||||
|
2023
Q1 | $21.3M | Buy |
|
|||||
|
2022
Q4 | $11.2M | Buy |
|
|||||
|
2022
Q3 | $16.4M | Buy |
|
|||||
|
2022
Q2 | $15.7M | Sell |
|
|||||
|
2022
Q1 | $20.8M | Buy |
|
|||||
|
2021
Q4 | $28.4M | Buy |
|
|||||
|
2021
Q3 | $36.8M | Buy |
|
|||||
|
2021
Q2 | $52M | Buy |
|
|||||
|
2021
Q1 | $59.8M | Buy |
|
|||||
|
2020
Q4 | $73.5M | Buy |
|
|||||
|
2020
Q3 | $22.7M | Sell |
|
|||||
|
2020
Q2 | $25.1M | Buy |
|
|||||
|
2020
Q1 | $10.4M | Buy |
|
|||||
|
2019
Q4 | $7.93M | Sell |
|
|||||
|
2019
Q3 | $6.11M | Buy |
|
|||||
|
2019
Q2 | $8.24M | Buy |
|
|||||
|
2019
Q1 | $6.5M | Buy |
|
|||||
|
2018
Q4 | $6.32M | Buy |
|
|||||
|
2018
Q3 | $9.82M | Buy |
|
|||||
|
2018
Q2 | $9.01M | Sell |
|
|||||
|
2018
Q1 | $8.75M | Buy |
|
|||||
|
2017
Q4 | $4.77M | Buy |
|
|||||
|
2017
Q3 | $6.36M | Buy |
|
|||||
|
2017
Q2 | $8.39M | Buy |
|
|||||
|
2017
Q1 | $8.37M | Buy |
|
|||||
|
2016
Q4 | $6.09M | Sell |
|
|||||
|
2016
Q3 | $5.15M | Buy |
|
|||||
|
2016
Q2 | $2.37M | Buy |
|
|||||
|
2016
Q1 | $4.4M | Buy |
|
|||||
|
2015
Q4 | $4.23M | Buy |
|
|||||
|
2015
Q3 | $6.04M | Buy |
|
|||||
|
2015
Q2 | $6.53M | Buy |
|
|||||
|
2015
Q1 | $7.26M | Buy |
|
|||||
|
2014
Q4 | $1.75M | Buy |
|
|||||
|
2014
Q3 | $588K | Buy |
|